NCT03748134 2023-10-24
Sintilimab or Placebo With Chemotherapy in Esophageal Squamous Cell Carcinoma ( ORIENT-15 )
Innovent Biologics (Suzhou) Co. Ltd.
Phase 3 Completed
Innovent Biologics (Suzhou) Co. Ltd.
Institut de Cancérologie de Lorraine
Blokhin's Russian Cancer Research Center
Japan Clinical Oncology Group
Shanghai Chest Hospital
Chinese University of Hong Kong